Publications by authors named "Alison C West"

13Publications

Constitutive STAT3 Serine Phosphorylation Promotes Helicobacter-Mediated Gastric Disease.

Am J Pathol 2020 06 19;190(6):1256-1270. Epub 2020 Mar 19.

Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2020.01.021DOI Listing
June 2020

Serine-Phosphorylated STAT3 Promotes Tumorigenesis via Modulation of RNA Polymerase Transcriptional Activity.

Cancer Res 2019 10 3;79(20):5272-5287. Epub 2019 Sep 3.

Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-0974DOI Listing
October 2019

Investigating the Role of Toll-Like Receptors in Mouse Models of Gastric Cancer.

Methods Mol Biol 2016 ;1390:427-49

Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3335-8_25DOI Listing
October 2016

The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.

J Cell Biochem 2016 Jan;117(1):49-58

School of Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.25246DOI Listing
January 2016

Inflammatory and non-inflammatory roles for Toll-like receptors in gastrointestinal cancer.

Curr Pharm Des 2015 ;21(21):2968-77

Cancer and Immune Signaling Laboratory, Centre for Innate Immunity and Infectious Diseases, MIMRPHI Institute of Medical Research, 27-31 Wright St, Clayton, Victoria, 3168 Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612821666150514104411DOI Listing
March 2016

Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.

Prostate 2015 May 7;75(7):723-34. Epub 2015 Feb 7.

Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, 7000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22954DOI Listing
May 2015

The anticancer effects of HDAC inhibitors require the immune system.

Oncoimmunology 2014 Jan;3(1):e27414

Cancer Therapeutics Program; The Peter MacCallum Cancer Centre; East Melbourne, VIC Australia ; Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville, VIC Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/onci.27414
Publisher Site
http://dx.doi.org/10.4161/onci.27414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962507PMC
January 2014

New and emerging HDAC inhibitors for cancer treatment.

J Clin Invest 2014 Jan 2;124(1):30-9. Epub 2014 Jan 2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI69738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871231PMC
January 2014

An intact immune system is required for the anticancer activities of histone deacetylase inhibitors.

Cancer Res 2013 Dec 24;73(24):7265-76. Epub 2013 Oct 24.

Authors' Affiliations: Cancer Therapeutics Program, and Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; Queensland Institute of Medical Research; and School of Medicine, University of Queensland, Herston, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0890DOI Listing
December 2013

The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects.

Oncoimmunology 2012 May;1(3):377-379

Cancer Therapeutics; The Peter MacCallum Cancer Centre; East Melbourne, Australia ; Cancer Immunology Program; The Peter MacCallum Cancer Centre; East Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.18804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382866PMC
May 2012

Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1.

Leuk Res 2010 Sep 1;34(9):1203-13. Epub 2010 May 1.

Menzies Research Institute, University of Tasmania, Tasmania, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.03.029DOI Listing
September 2010